Ken Fisher’s Kura Oncology KURA Stock Holding History

Ken Fisher’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.49M	Buy	675,305 +203,312	+43%	+$1.75M	﹤0.01%	458
2025 Q4	$4.9M	Buy	+471,993	New	+$4.95M	﹤0.01%	467

Other funds holding KURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ken Fisher's KURA Position: Q1 2026 in Review

Ken Fisher increased its Kura Oncology (KURA) stake by 43% in Q1 2026, buying an estimated $1.75M and bringing the position to 675,305 shares worth $5.49M. The position accounts for ﹤0.01% of the portfolio, ranked #458.

Ken Fisher first reported a position in KURA in Q4 2025 and has held it in 2 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

Ken Fisher held 675,305 shares of Kura Oncology worth $5.49M as of Q1 2026.
Ken Fisher bought 203,312 Kura Oncology shares in Q1 2026, an estimated $1.75M.
Kura Oncology made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #458 holding.
Ken Fisher first reported a position in Kura Oncology in Q4 2025 and has held it in 2 quarters since.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.